MDS is Not Directly Associated with Skin Fragility
Myelodysplastic syndrome (MDS) is not characterized by skin fragility as a primary manifestation. The cutaneous manifestations of MDS include specific lesions (leukemia cutis), neutrophilic dermatoses (Sweet's syndrome), vasculitis, purpura, infections, and various inflammatory conditions—but not the skin fragility typically seen in conditions affecting collagen or dermal integrity 1, 2, 3.
What Skin Manifestations Actually Occur in MDS
The documented cutaneous findings in MDS patients include:
- Leukemia cutis (specific infiltration of malignant cells into skin) 3
- Purpura and ecchymoses related to thrombocytopenia (platelet counts <50,000/mm³ occur in ~30% of lower-risk MDS) 1, 4
- Neutrophilic dermatoses such as Sweet's syndrome 2
- Leucocytoclastic vasculitis 2
- Photosensitivity 2
- Prurigo nodularis 2
- Infections due to neutropenia 1
Critical Distinction: Purpura vs. Skin Fragility
The purpura seen in MDS results from thrombocytopenia (low platelet counts), not from skin fragility. This is fundamentally different from conditions like senile purpura or corticosteroid-induced skin fragility where the skin itself is structurally compromised 4. In MDS:
- Bleeding occurs because of inadequate platelet numbers or function
- The skin structure remains intact
- Trauma causes bleeding into skin due to coagulation defects, not because the skin tears easily
Clinical Significance of Skin Findings
When skin lesions do appear in MDS patients, they carry important prognostic implications:
- Skin manifestations predict high-risk MDS (odds ratio 3.59) and are associated with hypergammaglobulinemia 2
- Unusual specific cutaneous lesions (ecchymoses, necrotic plaques, ulcers, prurigo-like lesions) can herald or accompany acute transformation to leukemia in 75% of cases 3
- Early biopsy is indicated when any cutaneous lesions appear in MDS patients to detect leukemia cutis or transformation 2, 3
Common Pitfall to Avoid
Do not confuse the purpura/ecchymoses from thrombocytopenia with true skin fragility. If an MDS patient presents with what appears to be "fragile skin," consider:
- Thrombocytopenia-related bleeding (check platelet count)
- Concurrent corticosteroid use (if on immunosuppressive therapy)
- Age-related senile purpura (common in elderly MDS patients but unrelated to MDS itself) 4
- Vasculitis (requires biopsy for diagnosis) 2
The skin itself in MDS maintains normal structural integrity unless there is a separate, unrelated condition causing fragility.